Location: Home
  • search
  • go
  • Relate News
  • 8/1/2025Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...
  • 8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
  • 8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
  • 8/1/2025What the Latest Volume-Based Procurement Changes in China Mean for Pha...
  • 7/31/2025China's Plan to Boost Drug Coverage by Commercial Insurers No 'Magic W...
  • 7/31/2025U.S. Closes Bribery Investigation into GE Healthcare's China Operation...
  • 7/31/2025GE HealthCare Q2 Results Highlight Mixed Signals in China Amid Tariff ...
  • 7/31/2025China's 'Silver Yuan' Set to Power US$134B Boom in Geriatric Healthcar...
  • 7/31/2025R&B Bio Secures New Funding Round Led by SBI Holdings
  • 7/31/2025Leto Lab Secures Series D Financing Led by Hankang Capital
  • 7/31/2025Ancocare Closes Series B Financing to Fuel Oncolytic Virus Pipeline E...
  • 7/31/2025DarwinCell Breaks Ground with CNY 200M Series C Financing from Tsing C...
  • 7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...
  • 7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China
  • 7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...
  • 7/31/2025China Seeks Feedback on Draft Guidelines for Eosinophilic Esophagitis ...
  • 7/30/2025SPH Biothera Receives NMPA Clearance for CAR-T Therapy Targeting Refra...
  • 7/30/2025Zhongmou Thera Secures Major Funding to Advance Gene Therapy Pipleline
  • 7/30/2025Dr. Falk Pharma and Allianthera Partner to Advance Novel AhR Agonist f...
  • 7/30/2025Madrigal Secures Global Rights to CSPC's Oral GLP-1 Candidate in Majo...
  • 7/30/2025China Approves Domestic CD19 CAR-T Therapy Hengkailai
  • 7/30/2025J&J's Lazcluze Approved for NSCLC in China
  • 7/30/2025AstraZeneca's Lynparza Gains Approval for New Indication in China
  • 7/30/2025CDE Issues Technical Guidance on Model-Informed Drug Development for R...
  • 7/30/2025CDE Issues New Guidance on Clinical Pharmacology Research for Rare Dis...
  • 7/30/2025CDE Releases New Guidelines on Impurity Limits for Fermentation or Sem...
  • 7/30/2025CDE Issues Technical Guidelines on Drug Exposure–Response Relationshi...
  • 7/29/2025Bayer Files HER2+ Lung Cancer Drug in China
  • 7/29/2025Hengrui Boosts R&D Ambitions with Strategic Stake Purchase in Shengdi ...
  • 7/29/2025LENZ Moves Toward Approval in China with LNZ100 Submission
  • Page:23/803 Total number of articles:24071: [First][<<] [21] [22] [23] [24] [25] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group